Gladstone Institutional Advisory’s iShares Biotechnology ETF IBB Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $495K | Buy |
3,909
+254
| +7% | +$32.1K | 0.02% | 496 |
|
2025
Q1 | $468K | Sell |
3,655
-216
| -6% | -$27.6K | 0.02% | 485 |
|
2024
Q4 | $512K | Sell |
3,871
-520
| -12% | -$68.8K | 0.02% | 468 |
|
2024
Q3 | $639K | Sell |
4,391
-977
| -18% | -$142K | 0.03% | 395 |
|
2024
Q2 | $737K | Sell |
5,368
-63
| -1% | -$8.65K | 0.04% | 352 |
|
2024
Q1 | $745K | Sell |
5,431
-885
| -14% | -$121K | 0.04% | 333 |
|
2023
Q4 | $858K | Buy |
6,316
+420
| +7% | +$57.1K | 0.05% | 315 |
|
2023
Q3 | $721K | Buy |
5,896
+49
| +0.8% | +$5.99K | 0.05% | 322 |
|
2023
Q2 | $742K | Sell |
5,847
-639
| -10% | -$81.1K | 0.05% | 328 |
|
2023
Q1 | $838K | Sell |
6,486
-388
| -6% | -$50.1K | 0.05% | 321 |
|
2022
Q4 | $903K | Sell |
6,874
-1,289
| -16% | -$169K | 0.06% | 294 |
|
2022
Q3 | $955K | Sell |
8,163
-359
| -4% | -$42K | 0.07% | 275 |
|
2022
Q2 | $1M | Buy |
8,522
+131
| +2% | +$15.4K | 0.08% | 271 |
|
2022
Q1 | $1.09M | Sell |
8,391
-4,879
| -37% | -$636K | 0.07% | 280 |
|
2021
Q4 | $2.03M | Buy |
13,270
+1,988
| +18% | +$303K | 0.16% | 174 |
|
2021
Q3 | $1.82M | Sell |
11,282
-222
| -2% | -$35.9K | 0.18% | 151 |
|
2021
Q2 | $1.88M | Buy |
11,504
+153
| +1% | +$25K | 0.22% | 112 |
|
2021
Q1 | $1.71M | Buy |
11,351
+5,641
| +99% | +$849K | 0.27% | 94 |
|
2020
Q4 | $865K | Sell |
5,710
-50
| -0.9% | -$7.57K | 0.17% | 116 |
|
2020
Q3 | $780K | Buy |
5,760
+340
| +6% | +$46K | 0.19% | 111 |
|
2020
Q2 | $741K | Buy |
5,420
+668
| +14% | +$91.3K | 0.19% | 104 |
|
2020
Q1 | $512K | Buy |
4,752
+1,749
| +58% | +$188K | 0.13% | 138 |
|
2019
Q4 | $362K | Sell |
3,003
-67
| -2% | -$8.08K | 0.09% | 171 |
|
2019
Q3 | $306K | Sell |
3,070
-1,681
| -35% | -$168K | 0.08% | 202 |
|
2019
Q2 | $518K | Buy |
4,751
+1,428
| +43% | +$156K | 0.16% | 131 |
|
2019
Q1 | $372K | Buy |
3,323
+269
| +9% | +$30.1K | 0.14% | 138 |
|
2018
Q4 | $294K | Buy |
+3,054
| New | +$294K | 0.17% | 129 |
|